Access Statistics for Jeffrey Hoch

Author contact details at EconPapers.

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis 0 0 0 7 0 1 1 21
A Review and Meta-analysis of Colorectal Cancer Utilities 0 0 0 1 1 3 6 10
A Tutorial on Net Benefit Regression for Real-World Cost-Effectiveness Analysis Using Censored Data from Randomized or Observational Studies 0 0 0 0 0 0 8 10
Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters 0 0 0 7 0 0 1 23
Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors 0 0 0 0 0 0 0 0
Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results 0 1 2 2 0 2 6 8
Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom 0 0 0 1 0 0 1 18
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology 0 0 0 1 0 0 1 10
Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale? 0 0 0 1 0 1 2 17
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening 0 0 0 0 0 1 1 2
Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions 0 0 0 15 0 1 1 132
Measuring and illustrating statistical evidence in a cost-effectiveness analysis 0 0 0 9 0 1 3 67
Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR) 0 0 0 0 0 0 0 13
Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment 0 0 0 8 0 1 1 51
Public engagement in priority-setting: Results from a pan-Canadian survey of decision-makers in cancer control 0 0 0 2 2 3 4 35
Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data 1 1 1 143 2 3 7 492
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis 0 1 1 138 0 3 5 1,156
The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada 0 0 0 7 1 1 2 29
The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study 0 0 0 0 0 0 0 7
Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation 0 0 0 6 0 1 1 63
Total Journal Articles 1 3 4 348 6 22 51 2,164


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Econometric Considerations When Using the Net Benefit Regression Framework to Conduct Cost-effectiveness Analysis 0 0 0 2 4 4 5 10
Improving the Efficiency of Cost-effectiveness Analysis to Inform Policy Decisions in the Real World: Lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario 0 0 0 0 1 2 7 9
Labs and cases in health insurance and cost-effectiveness analyses to enhance active learning experiences in an introductory healtheconomics course for students in health professions 0 1 1 6 0 1 1 9
Using net benefit regression to teach cost-effectiveness analysis with a dataset 0 1 3 21 1 4 11 48
Total Chapters 0 2 4 29 6 11 24 76


Statistics updated 2025-12-06